photosensitive epilepsy

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Photosensitive Epilepsy Trial in Boston (Fenfluramine Hydrochloride)

Active, not recruiting
  • Photosensitive Epilepsy
  • Fenfluramine Hydrochloride
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 16, 2022

Photosensitive Epilepsy Trial in United States (Placebo, E2082)

Terminated
  • Photosensitive Epilepsy
  • Little Rock, Arkansas
  • +4 more
Sep 4, 2020

Photosensitive Epilepsy Trial in Saint Louis (BRV vs LEV in randomized double blinded, crossover fashion)

Completed
  • Photosensitive Epilepsy
  • BRV vs LEV in randomized double blinded, crossover fashion
  • Saint Louis, Missouri
    The Comprehensive Epilepsy Care Center For Children And Adults
Mar 25, 2019

Photosensitive Epilepsy Trial in France, Germany (ACT-709478 for oral use, Placebo)

Completed
  • Photosensitive Epilepsy
  • ACT-709478 for oral use
  • Placebo
  • Le Kremlin-BicĂȘtre, France
  • +4 more
Aug 30, 2018

Photosensitive Epilepsy Trial in Chesterfield, Nashville (Valproic Acid, Placebo)

Completed
  • Photosensitive Epilepsy
  • Valproic Acid
  • Placebo
  • Chesterfield, Missouri
  • +1 more
May 18, 2017

Photosensitive Epilepsy Trial in Germany (BGG492, Placebo)

Completed
  • Photosensitive Epilepsy
  • Bielefeld, Germany
  • +3 more
Sep 21, 2016

Photosensitive Epilepsy Trial (JNJ-26489112, Placebo)

Completed
  • Photosensitive Epilepsy
  • (no location specified)
Apr 3, 2012

Photosensitive Epilepsy Trial in Baltimore, New York (carbamazepine 400mg, levetiracetam 1000mg)

Completed
  • Photosensitive Epilepsy
  • carbamazepine 400mg
  • levetiracetam 1000mg
  • Baltimore, Maryland
  • +1 more
Mar 1, 2012